Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Wolfgang H. Jost, Armin Steffen & Steffen Berweck. (2021) A critical review of incobotulinumtoxinA in the treatment of chronic sialorrhea in pediatric patients. Expert Review of Neurotherapeutics 21:10, pages 1059-1068.
Read now
Read now
Articles from other publishers (21)
Antonella GIANNANTONI, Marilena GUBBIOTTI, Emanuele RUBILOTTA, Matteo BALZARRO, Alessandro ANTONELLI & Vittorio BINI. (2022) IncobotulinumtoxinA versus onabotulinumtoxinA intradetrusor injections in patients with neurogenic detrusor overactivity incontinence: a double-blind, randomized, non-inferiority trial. Minerva Urology and Nephrology 74:5.
Crossref
Crossref
Marco Pirazzini, Cesare Montecucco & Ornella Rossetto. (2022) Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update. Archives of Toxicology 96:6, pages 1521-1539.
Crossref
Crossref
Francois Giuliano, Pierre Denys & Charles Joussain. (2022) Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series. Toxins 14:4, pages 286.
Crossref
Crossref
Silke Neusser, Cordula Kreuzenbeck, Kathrin Pahmeier, Beate Lux, Alexander Wilke, Jürgen Wasem & Anja Neumann. (2019) Budget impact of botulinum toxin treatment for spasticity after stroke — a German perspective. Journal of Public Health 29:4, pages 735-741.
Crossref
Crossref
Z. A. Zalyalova. (2021) Benign essential blepharospasm: epidemiology, clinical manifestations, pathophysiology, botulinum toxin therapy. Neurology, Neuropsychiatry, Psychosomatics 13:1, pages 119-125.
Crossref
Crossref
Dimos D. Mitsikostas, Andrzej Dekundy, Kati Sternberg, Michael Althaus & Fernando Pagan. (2020) IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial. Advances in Therapy 37:10, pages 4249-4265.
Crossref
Crossref
Babak Afsharipour, Sourav Chandra, Guijin Li, William Z. Rymer & Nina L. Suresh. (2020) Characterization of Differences in the Time Course of Reflex and Voluntary Responses Following Botulinum Toxin Injections in Chronic Stroke Survivors. IEEE Transactions on Neural Systems and Rehabilitation Engineering 28:7, pages 1642-1650.
Crossref
Crossref
David Rupp, Greg Nicholson, David Canty, Joanne Wang, Catherine Rhéaume, Linh Le, Lance E. Steward, Mark Washburn, Birgitte P. Jacky, Ron S. Broide, Wolfgang G. Philipp-Dormston, Mitchell F. Brin & Amy Brideau-Andersen. (2020) OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Toxins 12:6, pages 393.
Crossref
Crossref
José Raúl Montes. 2020. Avoiding and Managing Complications in Cosmetic Oculofacial Surgery. Avoiding and Managing Complications in Cosmetic Oculofacial Surgery
259
270
.
Anna Kutschenko, Hans Bigalke, Florian Wegner & Kai Wohlfarth. (2019) The role of human serum albumin and neurotoxin associated proteins in the formulation of BoNT/A products. Toxicon 168, pages 158-163.
Crossref
Crossref
Laure Mathevon, Arnaud Declemy, Isabelle Laffont & Dominic Perennou. (2019) Immunogenicity induced by botulinum toxin injections for limb spasticity: A systematic review. Annals of Physical and Rehabilitation Medicine 62:4, pages 241-251.
Crossref
Crossref
Babak Afsharipour, Guijin Li, Sourav Chandra, William Z. Rymer & Nina L. Suresh. (2019) Variations of Tendon Tap Force Threshold needed to Evoke Surface Electromyogram Responses after Botulinum Toxin Injection in Chronic Stroke Survivors. Variations of Tendon Tap Force Threshold needed to Evoke Surface Electromyogram Responses after Botulinum Toxin Injection in Chronic Stroke Survivors.
Luis Jerez Palacios & Doris Valencia V. (2018) Effectiveness of botulinum toxin type A for pain control in children with spastic cerebral palsy. Revista Colombiana de Médicina Física y Rehabilitación 28:1, pages 13-24.
Crossref
Crossref
Javier Martínez-Poles, Velina Nedkova-Hristova, José Escribano-Paredes, Sebastián García-Madrona, Elena Natera-Villalba, Carlos Estévez-Fraga, José López-Sendón Moreno, Icíar Avilés-Olmos, Gema Sánchez Díaz, Juan Martínez Castrillo & Araceli Alonso-Canovas. (2018) Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience. Toxins 10:6, pages 217.
Crossref
Crossref
Jeffrey S. DoverGary MonheitMark GreenerAndy Pickett. (2018) Botulinum Toxin in Aesthetic Medicine: Myths and Realities. Dermatologic Surgery 44:2, pages 249-260.
Crossref
Crossref
Frank J. Lebeda, Zygmunt F. Dembek & Michael Adler. 2018. Foodborne Diseases. Foodborne Diseases
275
308
.
Marco Pirazzini, Ornella Rossetto, Roberto Eleopra & Cesare Montecucco. (2017) Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacological Reviews 69:2, pages 200-235.
Crossref
Crossref
A. L. Kurenkov, O. A. Klochkova, B. I. Bursagova, H. M. Karimova, L. M. Kuzenkova, A. M. Mamedyarov, L. S. Namazova-Baranova, O. V. Agranovich, A. O. Agranovich, O. A. Soboleva, M. M. Khapaeva, T. T. Batysheva & M. N. Sarzhina. (2017) Efficacy and safety of botulinum toxin type A (IncobotulinumtoxinA) in the treatment of patients with cerebral palsy. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:11, pages 37.
Crossref
Crossref
Olga Vagin & David O. Beenhouwer. (2016) Septins: Regulators of Protein Stability. Frontiers in Cell and Developmental Biology 4.
Crossref
Crossref
Yvette N. Lamb & Lesley J. Scott. (2016) IncobotulinumtoxinA: A Review in Upper Limb Spasticity. Drugs 76:14, pages 1373-1379.
Crossref
Crossref
Shilpadevi Patil, Olga Willett, Terin Thompkins, Robert Hermann, Sathish Ramanathan, Elyse M. Cornett, Charles J. Fox & Alan David Kaye. (2016) Botulinum Toxin: Pharmacology and Therapeutic Roles in Pain States. Current Pain and Headache Reports 20:3.
Crossref
Crossref